Market News
Accretion Pharmaceuticals IPO opens on May 9; check price band, lot size & more
3 min read | Updated on May 13, 2025, 12:48 IST
SUMMARY
Accretion Pharmaceuticals IPO opens for subscription from May 14 to 16, aiming to raise ₹29.75 crore via the SME route. The IPO price band is ₹96 to ₹101 per share with a lot size of 1,200 shares. Net IPO proceeds will be used for capital expenditure towards the purchase of new equipment, repayment of loans and general corporate purposes.
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing pharma products like tablets, capsules, oral liquids and others.
Accretion Pharmaceuticals IPO will open for subscription on May 14. The pharma product manufacturer aims to raise ₹29.75 crore through its initial public offering. The IPO will remain open till May 16.
Accretion Pharmaceuticals IPO details
Accretion Pharmaceuticals aims to raise ₹29.75 crore through its SME IPO. The issue is 100% book-built and made up entirely of a fresh issuance of 29.4 lakh shares, with no offer-for-sale (OFS) component.
The company has fixed the price band of the issue at ₹96 to ₹101 per share. The lot size, or the minimum bid quantity to apply for the issue, is 1,200 shares. This equates to a minimum investment amount of over ₹1.2 lakh for retail investors (if bids are placed at the upper end of the price band) and ₹2.42 lakh for high networth investors (HNIs) as they need to bid for a minimum of 2 lots.
Accretion Pharmaceuticals has appointed Jawa Capital Services Private Limited as the book-running lead manager of the IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for the Rapid Fleet IPO is Gretex Share Broking Private Limited.
Accretion Pharmaceuticals IPO: Important dates
The Accretion Pharmaceuticals IPO will remain open for bidding from 14 to 16 May. After the bidding is closed, the allotment of shares is expected to be finalised on May 19.
Successful bidders can expect the shares to be credited to their demat accounts by May 20, with others receiving refunds on the same day. Accretion Pharmaceuticals shares are scheduled to list on the NSE Emerge platform on May 21.
Accretion Pharmaceuticals IPO: Use of proceeds
| Particulars | Estimated amount |
|---|---|
| Capex to purchase new equipment | The company will use ₹2.69 crore to purchase new equipment/machineries. |
| Capex for upgradation | The company will use ₹4.65 crore to fund capital expenditure to upgrade its existing manufacturing facility |
| Repayment of borrowings | The company will utilise ₹0.99 crore to repay or prepay some of its outstanding borrowings. |
| Working capital requirements | The company will use ₹14.68 crore to fund working capital requirements |
| General corporate purposes | The company will spend ₹6.7 crore towards its general corporate purposes. |
About the company
Incorporated in 2012, Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing tablets, capsules, oral liquids, and external preparations (Ointment, Cream, Gel, Lotion & more). The company operates on a B2B model, serving domestic and export clients through direct sales and contract manufacturing. It earned 72.9% of its total revenue from the top 10 clients in FY24. The company has a manufacturing facility in Sanand, which has advanced machinery and efficient processes tailored to customer demand.
About The Author
Next Story
